PK Study of Liquid Formulation of BIO89-100 in Subjects With NASH With Compensation Cirrhosis
Clinical trial NCT05022693 · COMPLETED
Trial details
- NCT number
- NCT05022693
- Sponsor
- 89bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-16
- Primary completion
- 2021-12-21
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.